Quarterly report · Q2

Period2023-01-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥10.7bn2023-01-01 → 2023-06-30Cons.Net sales
Revenue¥14.2bn2022-01-01 → 2022-12-31Cons.Net sales (5-year summary)
Revenue¥7.0bn2022-01-01 → 2022-06-30Cons.Net sales
Operating income¥2.4bn2023-01-01 → 2023-06-30Cons.Operating income
Operating income¥1.3bn2022-01-01 → 2022-06-30Cons.Operating income
Ordinary income¥2.8bn2023-01-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥1.5bn2022-01-01 → 2022-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.4bn2022-01-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥2.8bn2023-01-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥1.4bn2022-01-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥1.9bn2023-01-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.0bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥969m2022-01-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥1.9bn2023-01-01 → 2023-06-30Cons.Profit loss
Net income¥970m2022-01-01 → 2022-06-30Cons.Profit loss
Total assets¥24.5bnat 2023-06-30Cons.Assets
Total assets¥21.8bnat 2022-12-31Cons.Assets
Total assets¥20.9bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥7.3bnat 2023-06-30Cons.Liabilities
Total liabilities¥6.6bnat 2022-12-31Cons.Liabilities
Net assets / equity¥17.2bnat 2023-06-30Cons.Net assets
Net assets / equity¥15.2bnat 2022-12-31Cons.Net assets
Net assets / equity¥14.8bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥16.0bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥14.4bnat 2022-12-31Cons.Cash and deposits
Cash & equivalents¥15.9bnat 2023-06-30Cons.Cash and cash equivalents
Cash & equivalents¥14.4bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥14.5bnat 2022-06-30Cons.Cash and cash equivalents
Cash & equivalents¥14.0bnat 2021-12-31dCons.Cash and cash equivalents
Operating cash flow¥2.8bn2023-01-01 → 2023-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥2.0bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.3bn2022-01-01 → 2022-06-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥805m2023-01-01 → 2023-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥751m2022-01-01 → 2022-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥366m2022-01-01 → 2022-06-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥385m2023-01-01 → 2023-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥927m2022-01-01 → 2022-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥449m2022-01-01 → 2022-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥58.482023-01-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥47.292023-04-01 → 2023-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥31.772022-01-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥30.322022-01-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥31.292022-04-01 → 2022-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥57.652023-01-01 → 2023-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥31.162022-01-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥29.712022-01-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio69.9%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio69.1%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio70.2%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 34
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-06-30−¥1m
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-06-30−¥1m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-06-30−¥1.2bn
jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segmentrevenue2023-01-01 → 2023-06-30¥2.9bn
jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segmentrevenue external2023-01-01 → 2023-06-30¥2.9bn
jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segmentsegment profit2023-01-01 → 2023-06-30−¥38m
jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segmentrevenue2023-01-01 → 2023-06-30¥178m
jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segmentrevenue external2023-01-01 → 2023-06-30¥178m
jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segmentsegment profit2023-01-01 → 2023-06-30−¥121m
jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segmentrevenue2023-01-01 → 2023-06-30¥7.7bn
jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segmentrevenue external2023-01-01 → 2023-06-30¥7.7bn
jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segmentrevenue intersegment2023-01-01 → 2023-06-30¥1m
jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segmentsegment profit2023-01-01 → 2023-06-30¥3.8bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-01-01 → 2023-06-30¥10.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-01-01 → 2023-06-30¥10.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-01-01 → 2023-06-30¥1m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-01-01 → 2023-06-30¥3.6bn
Reconciling Itemsreconcilingrevenue2022-01-01 → 2022-06-30−¥1m
Reconciling Itemsreconcilingrevenue intersegment2022-01-01 → 2022-06-30−¥1m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-06-30−¥1.1bn
jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥1.5bn
jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥1.5bn
jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segmentsegment profit2022-01-01 → 2022-06-30−¥224m
jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segmentrevenue2022-01-01 → 2022-06-30¥160m
jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segmentrevenue external2022-01-01 → 2022-06-30¥160m
jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segmentsegment profit2022-01-01 → 2022-06-30−¥24m
jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥5.3bn
jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥5.3bn
jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segmentrevenue intersegment2022-01-01 → 2022-06-30¥1m
jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segmentsegment profit2022-01-01 → 2022-06-30¥2.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-01-01 → 2022-06-30¥7.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-01-01 → 2022-06-30¥7.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-01-01 → 2022-06-30¥1m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-01-01 → 2022-06-30¥2.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 520
ItemContextValueUnit
Depreciation sgaPrior1YTDDuration94000000JPY
Depreciation sgaCurrentYTDDuration83000000JPY
Business consignment expenses sgaPrior1YTDDuration343000000JPY
Business consignment expenses sgaCurrentYTDDuration398000000JPY
Advertising expenses sgaPrior1YTDDuration349000000JPY
Advertising expenses sgaCurrentYTDDuration267000000JPY
Provision of allowance for doubtful accounts sgaPrior1YTDDuration4000000JPY
Provision of allowance for doubtful accounts sgaCurrentYTDDuration6000000JPY
Provision for others sgaPrior1YTDDuration14000000JPY
Provision for others sgaCurrentYTDDuration133000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E33586-000RecruitmentPlatformBusinessReportableSegmentMember5327000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E33586-000MedicalPlatformBusinessReportableSegmentMember1544000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E33586-000NewBusinessDevelopmentServicesReportableSegmentMember160000000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember7031000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember-JPY
Revenues from external customersPrior1YTDDuration7031000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E33586-000RecruitmentPlatformBusinessReportableSegmentMember1000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E33586-000MedicalPlatformBusinessReportableSegmentMember-JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E33586-000NewBusinessDevelopmentServicesReportableSegmentMember-JPY
Transactions with other segmentsPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember1000000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-1000000JPY
Transactions with other segmentsPrior1YTDDuration-JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E33586-000RecruitmentPlatformBusinessReportableSegmentMember5328000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E33586-000MedicalPlatformBusinessReportableSegmentMember1544000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E33586-000NewBusinessDevelopmentServicesReportableSegmentMember160000000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember7033000000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember-1000000JPY
Net salesPrior1YTDDuration7031000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E33586-000RecruitmentPlatformBusinessReportableSegmentMember2595000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E33586-000MedicalPlatformBusinessReportableSegmentMember-224000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E33586-000NewBusinessDevelopmentServicesReportableSegmentMember-24000000JPY
Operating incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember2346000000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember-1074000000JPY
Operating incomePrior1YTDDuration1272000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E33586-000RecruitmentPlatformBusinessReportableSegmentMember7654000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E33586-000MedicalPlatformBusinessReportableSegmentMember2874000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E33586-000NewBusinessDevelopmentServicesReportableSegmentMember178000000JPY
Revenues from external customersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember10707000000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember-JPY
Revenues from external customersCurrentYTDDuration10707000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E33586-000RecruitmentPlatformBusinessReportableSegmentMember1000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E33586-000MedicalPlatformBusinessReportableSegmentMember-JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E33586-000NewBusinessDevelopmentServicesReportableSegmentMember-JPY
Transactions with other segmentsCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember1000000JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember-1000000JPY
Transactions with other segmentsCurrentYTDDuration-JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E33586-000RecruitmentPlatformBusinessReportableSegmentMember7655000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E33586-000MedicalPlatformBusinessReportableSegmentMember2874000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E33586-000NewBusinessDevelopmentServicesReportableSegmentMember178000000JPY
Net salesCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember10709000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-12-31pass
balance sheet identityconsolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-01-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-01-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass